2601c paliperidone
Originaltitel der Bekanntmachung
Norway – Medical equipments, pharmaceuticals and personal care products – 2601c paliperidone
Opportunity Score
Warum diese Bewertung?
Chance
30 / 100
Komplexität
50 / 100
Risikofaktoren
The notice lacks estimated value, award criteria, and eligibility requirements. This makes it impossible to evaluate th...
All documents are in Norwegian, which may disadvantage non-Norwegian bidders.
Submission deadline in 1 days
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Überblick
Moderate opportunityWichtige Fakten
- Framework procurement
- Supplies contract
- 1 lot
- Duration until Jan 2028
- Supply of the active ingredient paliperidone
- Framework agreement with the four regional health authorities in Norway
Vollständige Zusammenfassung anzeigen
This tender by Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway, seeks to establish a framework agreement for the supply of the active ingredient paliperidone. The procedure is open, and electronic submission is required. However, critical information such as estimated value, award criteria, and eligibility requirements is missing from the notice, making it difficult to assess the opportunity fully.
Risiken
The notice lacks estimated value, award criteria, and eligibility requirements. This makes it impossible to evaluate th...
All documents are in Norwegian, which may disadvantage non-Norwegian bidders.
Submission deadline in 1 days
Analyse kann unvollständig sein
Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.
Wichtige Anforderungen
Technical
- Open procedure
- Place of performance: Norway
Administrative
- Electronic submission required
Anforderungen können unvollständig sein.
Zuschlagskriterien
Lot 1
Auftraggeber
Ort
VADSØ, NOR
Auftraggeberprofil
Kennung
916879067
Tätigkeit
Health
Lose (1)
LOT-0001
2601c paliperidone
Procurement of the active ingredient paliperidone for Norwegian health authorities. The framework agreement covers supplies over approximately 15 months (planned start November 2026, end January 2028).
Ort
Dauer
Kategorie
Zuschlagskriterien
Frist
Zuschlagsdetails
The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. Sykehusinnkjøp HF is procuring the active ingredient paliperidone.
Zusätzliche CPV-Codes
Hinweis zum Wert
Originale TED-Daten anzeigen
Originale TED-Beschreibung
The contracting authority for this competition is Sykehusinnkjøp HF, on behalf of the four regional health authorities in Norway: Helse Sør-Øst RHF, Helse Vest RHF, Helse Midt-Norway RHF and Helse Nord RHF. Sykehusinnkjøp HF is procuring the active ingredient paliperidone.
Vergabedetails
- Veröffentlichungsdatum
- 24 Jun 2026
- Sprachen
- English, Norwegian
Referenzmetadaten
- Rechtsgrundlage
- 32014L0024
Referenz-IDs
- Ausschreibungs-ID
- 434619-2026
Dokumente (2)
Ähnliche Ausschreibungen
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Belgium – Pharmaceutical products – Antimycotica
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Opportunity Score
Warum diese Bewertung?
Chance
30 / 100
Komplexität
50 / 100
Risikofaktoren
The notice lacks estimated value, award criteria, and eligibility requirements. This makes it impossible to evaluate th...
All documents are in Norwegian, which may disadvantage non-Norwegian bidders.
Submission deadline in 1 days
Tiefe Portfolioanalyse
Verwendet:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications